Power Law company profile

Orbital Therapeutics

Biotech & Life Sciences · San Francisco, United States · Founded 2022 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Revenue

$1–10M

Latest reported FY

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Investors

14 investors on Orbital Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 3 investors entered at this stage

Newpath Management

ARCH Venture Partners

Andreessen Horowitz

Series A 11 investors entered at this stage

Agent Capital

iGlobe Partners

Moore Strategic Ventures

Redmile Group

Invus

Casdin Capital

Abu Dhabi Growth Fund

Rellim Capital Management

Exor

Alexandria Venture Investments

Heritage Medical Systems

Global footprint

Where Orbital Therapeutics has talent and traffic

AI talent share

3.7% of workforce is AI talent
(1 of 27 staff)

Core AI00%

Other AI13.7%

Non-AI workforce2696.3%

Web traffic by country

4.1K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

See Orbital Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo